HOUSE DOCKET, NO. 2578 FILED ON: 1/19/2017
HOUSE . . . . . . . . . . . . . . . No. 2397
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Kevin J. Kuros
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act creating a commission to study increasing access to naloxone.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Kevin J. Kuros | 8th Worcester | 1/19/2017 |
Timothy R. Whelan | 1st Barnstable | 11/7/2017 |
Joseph D. McKenna | 18th Worcester | 11/7/2017 |
Ryan C. Fattman | Worcester and Norfolk | 11/7/2017 |
William L. Crocker, Jr. | 2nd Barnstable | 11/7/2017 |
Shawn Dooley | 9th Norfolk | 2/2/2017 |
Bradley H. Jones, Jr. | 20th Middlesex | 11/7/2017 |
Angelo L. D'Emilia | 8th Plymouth | 11/7/2017 |
Hannah Kane | 11th Worcester | 11/7/2017 |
David F. DeCoste | 5th Plymouth | 11/7/2017 |
Thomas J. Calter | 12th Plymouth | 11/7/2017 |
Paul K. Frost | 7th Worcester | 11/7/2017 |
Michael S. Day | 31st Middlesex | 11/7/2017 |
Bruce E. Tarr | First Essex and Middlesex | 11/7/2017 |
HOUSE DOCKET, NO. 2578 FILED ON: 1/19/2017
HOUSE . . . . . . . . . . . . . . . No. 2397
By Mr. Kuros of Uxbridge, a petition (accompanied by bill, House, No. 2397) of Kevin J. Kuros and others for an investigation by a special commission (including members of the General Court) of alternatives to naloxone and to broaden the availability of naloxone. Mental Health, Substance Use and Recovery. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninetieth General Court
(2017-2018)
_______________
An Act creating a commission to study increasing access to naloxone.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Notwithstanding any special or general law there shall be a special commission to study the alternatives and develop recommendations to broaden the availability of naloxone without prescription, including but not limited to recommendations on the standing order process, the collaborative practice agreement process, and/or legislative recommendations.
The special commission shall consist of: the secretary of health and human services or their designee, who shall serve as chair; the commissioner of the division of insurance or their designee; three members to be appointed by the governor, which shall include: one person who is a prescribing physician, one person who is a stakeholder within a retail pharmacy company, and one member of the general citizenry impacted by the opiate epidemic; two members of the house of representatives, one of whom to be appointed by the minority leader; two members of the senate, one of whom to be appointed by the minority leader; the director of the board of pharmacy or their designee; the director of the bureau of substance abuse services or their designee; provided, however, that the first meeting of the commission shall take place not later than January 1, 2018.
The special commission shall submit its recommendations, together with drafts of any legislation, to the clerks of the house of representative and the senate, the chairs of the joint committee on mental health and substance abuse not later than May 1, 2018.